Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5113233

Cc1ccc(-c2ccc(Cl)cc2NC(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 5/20 0.46
FABP5 Q01469 2/20 0.45
IDH2 P48735 2/20 0.42
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5113542 0.89 FABP4 (0.58) FABP4FABP5IDH2SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5103243 0.89 AKR1C3 (0.44) IDH2SMN1; SMN2MAPTRAB9AAKR1C3
Trifluoroacetic Acid SCHEMBL5103915 0.86 FABP4 (0.44) FABP4FABP5IDH2SMN1; SMN2AKR1C3
Trifluoroacetic Acid SCHEMBL5099366 0.86 CNR1 (0.45) FABP4FABP5IDH2TP53AKR1C3
Trifluoroacetic Acid SCHEMBL5103755 0.85 FFAR4 (0.44) FABP4FABP5IDH2FFAR1FFAR4
Trifluoroacetic Acid SCHEMBL5100417 0.84 FABP4 (0.45) FABP4FABP5IDH2MAPTPDK1
Trifluoroacetic Acid SCHEMBL5107023 0.83 IDH2 (0.45) IDH2PDK1PDK2PDK3PDK4
Trifluoroacetic Acid SCHEMBL5113759 0.82 KCNMA1 (0.45) FABP4FABP5IDH2FFAR1FFAR4
SCHEMBL5113237 0.82 FABP4 (0.41) FABP4FABP5IDH2SMN1; SMN2MAPT
Trifluoroacetic Acid SCHEMBL5103685 0.82 MEN1 (0.44) IDH2SMN1; SMN2RAB9ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 FABP4 4255/4885FABP5 1382/4885IDH2 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.